Table 1.
N. | Antigen | Start position | Peptide | Length |
---|---|---|---|---|
1 | KIF20A | 860 | Ac-SSTDSSPYARILRSRHSPLLK-amide | 21 |
2 | KIF2C | 356 | GDLSGKSQNASKGIYAMASRDVFLLKN-amide | 27 |
3 | MMP9 | 594 | RVFFFSGRQMWVYTGKTVLGPRSLDKLGL-amide | 29 |
4 | MNDA | 298 | Ac-NETSSVLEAAPKQMIEVPNCITRN -amide | 24 |
5 | OLFML2B | 50 | DNQENVLSQLLGDYDKVKAVSEGSD-amide | 25 |
6 | TROAP | 156 | Ac-KGGTTQRGQSARSSAYLAPRIPTH-amide | 24 |
7 | ULBP1 | 56 | Ac-LNRQPLFVYKDKKCHAIGAHRNSMNATKI-amide | 29 |
Amino acid sequences of each antigen were screened with EpiMatrix to identify epitopes with potential immune stimulatory properties in BALB/c mice. Putative regulatory T cells epitopes (Tregitopes), which promote suppression of vaccine-induced T cell responses, and autoimmune epitopes (autoepitopes) that have potential of inducing autoimmune reactions were selected against using JanusMatrix algorithm. For each antigen, a peptide that contained both MHC-I and -II epitopes was synthetized as listed and used for vaccination, or for detection of antigen-specific immune responses.